|Articles|June 29, 1994

Nuclear medicine slump hits Sopha

The downturn in the U.S. nuclearmedicine market hit Sopha Medical Systems last week. The U.S.subsidiary of French gamma camera maker Sopha Medical said itwould lay off about 9% of its work force in reaction to a declinein gamma camera orders over the

The downturn in the U.S. nuclearmedicine market hit Sopha Medical Systems last week. The U.S.subsidiary of French gamma camera maker Sopha Medical said itwould lay off about 9% of its work force in reaction to a declinein gamma camera orders over the last three quarters.

The nuclear medicine market nosedived in the fourth quarterof 1993, and by most accounts has yet to return to its formerstrength (SCAN 4/6/94). Gamma camera vendors have been scramblingto adapt, including Sopha competitor ADAC Laboratories, whichimplemented a similar downsizing earlier this year (SCAN 5/4/94).

Most of the lost jobs at Sopha will come from production andadministrative support personnel, the Columbia, MD-based companysaid. Sopha has taken pains to avoid impacting customer serviceor R&D, according to president Colin McNaught.


Related to this article

Does kV Still Matter in Photon-Counting CT?
Emerging research demonstrates the increasing stability of attenuation on clinically relevant VMIs with photon-counting CT and a redefined role of kV that may have implications for longitudinal quantitative CT.
CT Radiation Dosing: Where Things Stand, Part 2
In the second of a two-part interview, Kalpana Kanal, PhD, and Mahadevappa Mahesh, MS, PhD, FAPPM, FACR, discussed future directions for research on CT radiation dosing, including the potential of indication-specific diagnostic reference levels (DRLs).
CT Radiation Dosing: Where Things Stand, Part 1
In the first of a two-part interview, Kalpana Kanal, PhD, and Mahadevappa Mahesh, MS, PhD, FAPPM, FACR, discussed recently published research showing significant declines in computed tomography (CT) radiation dosing over the past decade.